Pharmacist‐provided non‐dispensing services in low‐ and middle‐income countries

Added May 10, 2020

Citation: Pande S, Hiller J, Nkansah N, et al. The effect of pharmacist‐provided non‐dispensing services on patient outcomes, health service utilisation and costs in low‐ and middle‐income countries. Cochrane Database of Systematic Reviews 2013; (2): CD010398

What is this? The COVID-19 pandemic is placing a great strain on healthcare services. Existing research on broadening pharmacists’ roles to provide health information and deal with medicine-related problems may provide useful information for policy makers.

In this Cochrane review, the authors searched for comparative effectiveness studies of pharmacist-provided non-dispensing services in low- and middle- income countries. They did their main searches in early 2010 and a supplementary search in September 2012. They included 12 randomised trials that were published up to 2010. These were from lower-middle income countries (7 studies) and upper-middle income countries (5). The authors’ September 2012 search identified an additional 26 articles, which are awaiting assessment.

What was found: Based on the studies included in the review, a patient-targeted pharmacist intervention was as effective or better than usual care for improving patient outcomes and health service utilisation, and for delivering patient counselling and care for drug therapy and management of the patient’s health condition.

Based on the studies included in the review, the effects of educational sessions by pharmacists for patients and healthcare professionals, including on costs and health outcomes are uncertain.

Based on the studies included in the review, the effects of pharmacist-provided services in low income countries are uncertain.


Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence on the coronavirus (COVID-19) but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about the coronavirus (COVID-19) on the basis of this summary alone.